These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36385996)

  • 21. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
    Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
    Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, Synthesis and Antitumor Activity of Novel link-bridge and B-Ring Modified Combretastatin A-4 (CA-4) Analogues as Potent Antitubulin Agents.
    Duan YT; Man RJ; Tang DJ; Yao YF; Tao XX; Yu C; Liang XY; Makawana JA; Zou MJ; Wang ZC; Zhu HL
    Sci Rep; 2016 May; 6():25387. PubMed ID: 27138035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, in vitro antiproliferative activity and apoptosis-inducing studies of 1-(3',4',5'-trimethoxyphenyl)-3-(2'-alkoxycarbonylindolyl)-2-propen-1-one derivatives obtained by a molecular hybridisation approach.
    Preti D; Romagnoli R; Rondanin R; Cacciari B; Hamel E; Balzarini J; Liekens S; Schols D; Estévez-Sarmiento F; Quintana J; Estévez F
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1225-1238. PubMed ID: 30141353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors.
    Mirzaei S; Eisvand F; Hadizadeh F; Mosaffa F; Ghasemi A; Ghodsi R
    Bioorg Chem; 2020 May; 98():103711. PubMed ID: 32179282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents.
    Song MY; He QR; Wang YL; Wang HR; Jiang TC; Tang JJ; Gao JM
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis and biological evaluation of novel acridine and quinoline derivatives as tubulin polymerization inhibitors with anticancer activities.
    Ren Y; Ruan Y; Cheng B; Li L; Liu J; Fang Y; Chen J
    Bioorg Med Chem; 2021 Sep; 46():116376. PubMed ID: 34455231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
    De Martino G; Edler MC; La Regina G; Coluccia A; Barbera MC; Barrow D; Nicholson RI; Chiosis G; Brancale A; Hamel E; Artico M; Silvestri R
    J Med Chem; 2006 Feb; 49(3):947-54. PubMed ID: 16451061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of (2-(phenylamino)thieno[3,2-d]pyrimidin-4-yl)(3,4,5-trimethoxyphenyl)methanone analogues as potent anti-tubulin polymerization agents.
    Tian C; Chen X; Zhang Z; Wang X; Liu J
    Eur J Med Chem; 2019 Dec; 183():111679. PubMed ID: 31541870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly potent triazole-based tubulin polymerization inhibitors.
    Zhang Q; Peng Y; Wang XI; Keenan SM; Arora S; Welsh WJ
    J Med Chem; 2007 Feb; 50(4):749-54. PubMed ID: 17249649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Biological Evaluation of 2-Methyl-4,5-Disubstituted Oxazoles as a Novel Class of Highly Potent Antitubulin Agents.
    Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Salvador MK; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Ronca R; Bortolozzi R; Mariotto E; Porcù E; Basso G; Viola G
    Sci Rep; 2017 Apr; 7():46356. PubMed ID: 28406191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and bioevaluation of 6-aryl-1-(3,4,5-trimethoxyphenyl)-1H-benzo[d]imidazoles as tubulin polymerization inhibitors.
    Liu R; Huang M; Zhang S; Li L; Li M; Sun J; Wu L; Guan Q; Zhang W
    Eur J Med Chem; 2021 Dec; 226():113826. PubMed ID: 34571171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylsulfanylpyridine based diheteroaryl isocombretastatin analogs as potent anti-proliferative agents.
    Álvarez R; Aramburu L; Gajate C; Vicente-Blázquez A; Mollinedo F; Medarde M; Peláez R
    Eur J Med Chem; 2021 Jan; 209():112933. PubMed ID: 33328100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of aryl azide derivatives of combretastatin A-4 as molecular probes for tubulin.
    Pinney KG; Mejia MP; Villalobos VM; Rosenquist BE; Pettit GR; Verdier-Pinard P; Hamel E
    Bioorg Med Chem; 2000 Oct; 8(10):2417-25. PubMed ID: 11058036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
    Sharma S; Gupta MK; Saxena AK; Bedi PM
    Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of Novel Quinoline-Chalcone Derivatives as Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.
    Li W; Xu F; Shuai W; Sun H; Yao H; Ma C; Xu S; Yao H; Zhu Z; Yang DH; Chen ZS; Xu J
    J Med Chem; 2019 Jan; 62(2):993-1013. PubMed ID: 30525584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, biological evaluation and cocrystal structures with tubulin of chiral β-lactam bridged combretastatin A-4 analogues as potent antitumor agents.
    Zhou P; Liang Y; Zhang H; Jiang H; Feng K; Xu P; Wang J; Wang X; Ding K; Luo C; Liu M; Wang Y
    Eur J Med Chem; 2018 Jan; 144():817-842. PubMed ID: 29306206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New thiazole-2(3H)-thiones containing 4-(3,4,5-trimethoxyphenyl) moiety as anticancer agents.
    Ansari M; Shokrzadeh M; Karima S; Rajaei S; Fallah M; Ghassemi-Barghi N; Ghasemian M; Emami S
    Eur J Med Chem; 2020 Jan; 185():111784. PubMed ID: 31669850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel pyrrol-2(3H)-ones and pyridazin-3(2H)-ones carrying quinoline scaffold as anti-proliferative tubulin polymerization inhibitors.
    Abdelbaset MS; Abuo-Rahma GEA; Abdelrahman MH; Ramadan M; Youssif BGM; Bukhari SNA; Mohamed MFA; Abdel-Aziz M
    Bioorg Chem; 2018 Oct; 80():151-163. PubMed ID: 29920422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tubulin inhibitors: Discovery of a new scaffold targeting extra-binding residues within the colchicine site through anchoring substituents properly adapted to their pocket by a semi-flexible linker.
    Maklad RM; AbdelHafez EMN; Abdelhamid D; Aly OM
    Bioorg Chem; 2020 Jun; 99():103767. PubMed ID: 32325332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.